Drug Profile
Research programme: PC-mAb companion diagnostic - Athera Biotechnologies
Alternative Names: CVDefine; IgM anti-PC kit - Athera BiotechnologiesLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Athera Biotechnologies
- Class Antibody diagnostics
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Atherosclerosis; Cardiovascular disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Atherosclerosis(Diagnosis) in Sweden
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cardiovascular-disorders(Diagnosis) in Sweden
- 26 Jun 2013 Preclinical trials in Atherosclerosis (diagnosis) in Sweden (unspecified route)